Skip to main content

Advertisement

SpringerLink
Log in

Oxidative stress parameters in localized scleroderma patients

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Localized scleroderma (LS) (morphea) is a chronic, inflammatory skin disease with unknown cause that progresses with sclerosis in the skin and/or subcutaneous tissues. Its pathogenesis is not completely understood. Oxidative stress is suggested to have a role in the pathogenesis of localized scleroderma. We have aimed to determine the relationship of morphea lesions with oxidative stress. The total oxidant capacity (TOC), total antioxidant capacity (TAC), paroxonase (PON) and arylesterase (ARES) activity parameters of PON 1 enzyme levels in the serum were investigated in 13 LS patients (generalized and plaque type) and 13 healthy controls. TOC values of the patient group were found higher than the TOC values of the control group (p < 0.01). ARES values of the patient group was found to be higher than the control group (p < 0.0001). OSI was significantly higher in the patient group when compared to the control (p < 0.005). Oxidative stress seems to be effective in the pathogenesis. ARES levels have increased in morphea patients regarding to the oxidative stress and its reduction. Further controlled studies are required in wider series.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abraham D, Distler O (2007) How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9(2):2

    Article  Google Scholar 

  2. Akoglu G, Emre S, Metin A, Akbas A, Yorulmaz A, Isıkoglu S, Sener S, Kilinc F (2013) Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo. Clin Exp Dermatol 38(7):701–706

    CAS  PubMed  Google Scholar 

  3. Akoglu G, Metin A, Kilinc F, Pektas SD, Isıkoglu S, Akbas A, Sener S (2013) Total serum oxidant/antioxidant status and arylesterase activity in recurrent aphthous stomatitis. Ann Dermatol 25(3):273–277

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Altindag O, Karakoc M, Soran N, Celik H, Celik N, Selek S (2007) Paraoxonase and arylesterase activities in patients with rheumatoid arthritis. Rheumatism 22:132–136

    Google Scholar 

  5. Arkachaisri T, Pino S (2008) Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. J Rheumatol 35:650–657

    Article  PubMed  Google Scholar 

  6. Aslan M, Horoz M, Nazlıgül Y, Bolukbas C, Bolukbas FF, Selek S, Aksoy N, Erel O (2008) Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis. Int J Clin Pract 62(7):1050–1055

    Article  CAS  PubMed  Google Scholar 

  7. Badea I, Taylor M, Rosenberg A, Foldvari M (2009) Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. Rheumatology 48(3):213–221

    Article  CAS  PubMed  Google Scholar 

  8. Balbir-Gurman A, Braun-Moscovici Y, Livshitz V, Schapira D, Markovits D, Rozin A, Boikaner T, Nahir AM (2007) Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis. Clin Rheumatol 26(9):1517–1521

    Article  PubMed  Google Scholar 

  9. Bozkurt M, Dag S, Oktayoglu P, Em S, Yuksel H, Caglayan M, Sariyildiz MA, Batmaz I, Ucar D, Nas K (2014) Serum prolidase enzyme activity and oxidative status in patients with scleroderma. Acta Medica Mediterranea 30:127–132

    Google Scholar 

  10. Brocard A, Quereux G, Moyse D, Drone B (2010) Localized scleroderma and zinc: a pilot study. Eur J Dermatol 20(2):172–174

    PubMed  Google Scholar 

  11. Careta MF, Romiti R (2015) Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol 90(1):62–73

    Article  PubMed  PubMed Central  Google Scholar 

  12. Christen-Zaech S, Hakim MD, Afsar FS, Paller AS (2008) Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol 59(3):385–396

    Article  PubMed  Google Scholar 

  13. Distler JH, Jungel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci- Cerinic M, Schett G, Marti HH, Gay S, Distler O (2007) Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum 56(12):4203–4215

    Article  CAS  PubMed  Google Scholar 

  14. Eckerson HW, Wyte MC, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35(6):1126–1138

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Emre S, Metin A, Demirseren DD, Kilic S, Isıkoglu S, Erel O (2013) The relationship between oxidative stress, smoking and the clinical severity of psoriasis. JEADV 27(3):370–375

    Google Scholar 

  16. Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37(4):277–285

    Article  CAS  PubMed  Google Scholar 

  17. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38(12):1103–1111

    Article  CAS  PubMed  Google Scholar 

  18. Gabrielli A, Svegliati S, Moroncini G, Amica D (2012) New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol J 6:87–95

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV (2008) Oxidative stress and the pathogenesis of scleroderma: the Murrell’s hypothesis revisited. Semin Immunopathol 30(3):329–337

    Article  CAS  PubMed  Google Scholar 

  20. Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 30(7):391–395

    CAS  PubMed  Google Scholar 

  21. Harma M, Harma M, Erel O (2005) Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 118:47–51

    Article  CAS  PubMed  Google Scholar 

  22. Isik A, Ustundag B (2006) Paraoxonase and arylesterase levels in behcet’s disease. F U Sag Bil Tıp Derg 20:307–315

    Google Scholar 

  23. Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT (2009) Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol 145(5):545–550

    Article  PubMed  PubMed Central  Google Scholar 

  24. Marasini M, Cugno M, Bassani C, Stanzani M, Bottasso B, Agostoni A (1992) Tissue-type plasminogen activator and Von Willebrand Factor plasma levels as marker of endothelial involvement in patients with Raynaud’s phenomenon. Int J Microcirc Clin Exp 11(4):375–382

    CAS  PubMed  Google Scholar 

  25. Peng SL, Fatenejad S, Craft J (1997) Scleroderma: a disease related to damaged proteins? Nat Med 3(3):276–278

    Article  CAS  PubMed  Google Scholar 

  26. Simonini G, Cerinic MM, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M (1999) Oxidative stres in systemic sclerosis. Mol Cell Biochem 196(1–2):85–91

    Article  CAS  PubMed  Google Scholar 

  27. Takehara K, Sato S (2005) Localized scleroderma is an autoimmune disorder. Rheumatology 44:274–279

    Article  CAS  PubMed  Google Scholar 

  28. Tikly M, Channa K, Theodorou P, Glumian M (2006) Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol 25(3):320–324

    Article  PubMed  Google Scholar 

  29. Tikly M, Marshall SE, Haldar NA, Gulumian M, Wordsworth P, Welsh KI (2004) Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis. Free Radic Biol Med 36(11):1403–1407

    Article  CAS  PubMed  Google Scholar 

  30. Toker A, Kadı M, Yildirim AK, Aksoy H, Akcay F (2009) Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 27(3):176–180

    Article  CAS  PubMed  Google Scholar 

  31. Tsou PS, Balogh B, Pinney AJ, Zakhem G, Lozier A, Amin MA, Stinson WA, Schiopu E, Khanna D, Fox DH, Koch AE (2014) Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts. Arthritis Res Ther 16(5):411

    Article  PubMed  Google Scholar 

  32. Uysal S, Akyol S, Hasgul R, Armutcu F, Yigitoglu MR (2011) Çok yönlü bir enzim: Paraoksonaz. Yeni Tıp Dergisi 28(3):136–141

    Google Scholar 

  33. Valančienė G, Jasaitienė D, Valiukevičienė S (2010) Pathogenesis and treatment modalities of localized scleroderma. Medicina (Kaunas) 46(10):649–656

    Google Scholar 

  34. Vasquez R, Sendejo C, Jacobe H (2012) Morphea and other forms of scleroderma. Curr Opin Rheumatol 24(6):685–693

    PubMed  Google Scholar 

  35. Veale DJ, Kırk G, Mclaren M, Belchh JJ (1998) Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis. Br J Rheumatol 37(11):1227–1228

    Article  CAS  PubMed  Google Scholar 

  36. Yamamoto T, Nishioka K (2005) Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Exp Dermatol 14(2):81–95

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Clinic, Ataturk Training and Research Hospital, 06800, Bilkent/Ankara, Turkey

    F. Kilinc, S. Sener & A. Akbaş

  2. Department of Dermatology, Yildirim Beyazit University Medical Faculty, Ankara, Turkey

    A. Metin

  3. Lokman Hekim Hospital, Ankara, Turkey

    S. Kirbaş

  4. Department of Biochemistry, Yildirim Beyazit University Medical Faculty, Ankara, Turkey

    S. Neselioglu & O. Erel

Authors
  1. F. Kilinc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Sener
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Akbaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Metin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Kirbaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Neselioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. Erel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Kilinc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kilinc, F., Sener, S., Akbaş, A. et al. Oxidative stress parameters in localized scleroderma patients. Arch Dermatol Res 308, 625–629 (2016). https://doi.org/10.1007/s00403-016-1682-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-016-1682-3

Keywords

Search

Navigation